title: A simple cost-effective lactate dehydrogenase level measurement can stratify patients with Ewing's tumor into low and high risk.
authors.forename: C M L
authors.initials: CM
authors.lastname: da Costa
authors.forename: A
authors.initials: A
authors.lastname: Lopes
authors.forename: B
authors.initials: B
authors.lastname: de Camargo
mesh_terms: D000293:Adolescent; D001859:Bone Neoplasms / Q000188:drug therapy / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007223:Infant; D007770:L-Lactate Dehydrogenase / Q000032:analysis* / Q000191:economics*; D008297:Male; D009367:Neoplasm Staging / Q000379:methods*; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000473:pathology*; D013534:Survival
chemical_list: D007770:L-Lactate Dehydrogenase